文献速递角膜与眼表疾病神经眼科

单纯疱疹病毒1型感染后小鼠角膜炎症与神经损伤由HVEM促进并可经免疫调节纳米颗粒疗法治愈

Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该研究在小鼠单纯疱疹病毒1型(HSV-1)感染模型中观察疱疹病毒侵入介导因子(HVEM)的细胞与时间表达模式及其对发病机制的影响,并评估HVEM缺失或免疫调节纳米颗粒(IMP)治疗的效果。结果显示角膜HVEM阳性单核/巨噬细胞和中性粒细胞在感染后增多,HVEM促进白细胞浸润和角膜敏感度丧失,而CD45+细胞HVEM缺失或静脉IMP治疗可减少慢性期浸润并维持角膜敏感度。

要点

  • 角膜HVEM阳性单核/巨噬细胞在急性感染期(3天)增多,中性粒细胞在慢性炎症期(14天)增多。
  • HVEM促进角膜白细胞增多和角膜敏感度丧失,且敏感度丧失先于白细胞浸润。
  • CD45+细胞HVEM缺失或静脉IMP治疗减少慢性期浸润并维持角膜敏感度。

核心结论

  • HVEM表达于角膜单核/巨噬细胞和中性粒细胞两种关键细胞群,并在慢性期促进髓系细胞向角膜募集。
  • HVEM相关的角膜敏感度丧失先于白细胞浸润,提示HVEM可能在招募中起主动作用。
  • 作者提出常驻角膜巨噬细胞上的HVEM增加神经损伤和免疫细胞侵入,并显示IMP治疗阻止晚期中性粒细胞和CD4+ T细胞浸润可改善临床症状和死亡率并减少HSV-1所致角膜敏感度丧失。

研究设计与样本

  • 研究使用C57BL/6小鼠感染HSV-1(17)后评估角膜HVEM水平。
  • 通过HVEM全局敲除(Tnfrsf14-/-)或条件性敲除比较白细胞浸润和角膜敏感度丧失。
  • 测量免疫调节纳米颗粒(IMP)对病毒复制、角膜敏感度和角膜浸润的影响。

主要发现

  • 角膜HVEM+细胞群在HSV-1感染后增加,急性感染期(3天)以单核/巨噬细胞为主,慢性炎症期(14天)以多形核中性粒细胞(PMN)为主。
  • HVEM增加角膜白细胞和角膜敏感度丧失。
  • CD45+细胞HVEM缺失或静脉IMP治疗减少慢性期浸润并维持角膜敏感度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine cellular and temporal expression patterns of herpes virus entry mediator (HVEM, Tnfrsf14) in the murine cornea during the course of herpes simplex virus 1 (HSV-1) infection, the impact of this expression on pathogenesis, and whether alterations in HVEM or downstream HVEM-mediated effects ameliorate corneal disease. METHODS: Corneal HVEM levels were assessed in C57BL/6 mice after infection with HSV-1(17). Leukocytic infiltrates and corneal sensitivity loss were measured in the presence, global absence (HVEM knockout [KO] mice; Tnfrsf14-/-), or partial absence of HVEM (HVEM conditional KO). Effects of immune-modifying nanoparticles (IMPs) on viral replication, corneal sensitivity, and corneal infiltrates were measured. RESULTS: Corneal HVEM+ populations, particularly monocytes/macrophages during acute infection (3 days post infection [dpi]) and polymorphonuclear neutrophils (PMN) during the chronic inflammatory phase (14 dpi), increased after HSV-1 infection. Herpes virus entry mediator increased leukocytes in the cornea and corneal sensitivity loss. Ablation of HVEM from CD45+ cells, or intravenous IMP therapy, reduced infiltrates in the chronic phase and maintained corneal sensitivity. CONCLUSIONS: Herpes virus entry mediator was expressed on two key populations: corneal monocytes/macrophages and PMNs. Herpes virus entry mediator promoted the recruitment of myeloid cells to the cornea in the chronic phase. Herpes virus entry mediator-associated corneal sensitivity loss preceded leukocytic infiltration, suggesting it may play an active role in recruitment. We propose that HVEM on resident corneal macrophages increases nerve damage and immune cell invasion, and we showed that prevention of late-phase infiltration of PMN and CD4+ T cells by IMP therapy improved clinical symptoms and mortality and reduced corneal sensitivity loss caused by HSV-1.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Edwards RG, Kopp SJ, Ifergan I, et al. Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci. 2017. PMID: 28114589. doi:10.1167/iovs.16-20668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。